Related Experiment Video
Updated: Aug 13, 2026

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform
Published on: May 3, 2024
The United States pediatric vaccine stockpile program
Kimberly S Lane1, Susan Y Chu, Jeanne M Santoli
1Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. KSB1@cdc.gov
The national vaccine stockpile needs expansion to cover today's complex immunization schedule. Strengthening this program is crucial for protecting against future vaccine supply disruptions.
Area of Science:
- Public Health
- Immunization Programs
- Vaccine Supply Chain Management
Background:
- The national vaccine stockpile was initially created in 1983 with a simpler immunization schedule.
- Early stockpiles contained fewer vaccines, focusing on measles-mumps-rubella, poliovirus, pertussis, diphtheria, and tetanus toxoids.
- Current vaccine needs have significantly increased compared to the program's inception.
Purpose of the Study:
- To evaluate the adequacy of the current national vaccine stockpile.
- To identify challenges and necessary considerations for future stockpile planning.
- To emphasize the importance of expanding and strengthening the national vaccine stockpile program.
Main Methods:
- The study reviews the historical goals and evolution of the national vaccine stockpile program.
- It analyzes the current complexities of childhood immunization schedules and vaccine production.
- The research considers factors such as vaccine costs, new combination vaccines, production timelines, and evolving recommendations.
Main Results:
- Current stockpiles do not encompass all recommended childhood vaccines.
- Prioritization has been given to universally recommended, fully implemented, single-manufacturer vaccines.
- Significant challenges for future planning include rising vaccine costs and new combination vaccines.
Conclusions:
- The national vaccine stockpile program requires expansion and strengthening.
- Future planning must account for increased vaccine costs, new formulations, varied production times, and updated recommendations.
- Enhancing the stockpile is critical to safeguard against future disruptions in vaccine availability.
Related Concept Videos
Smallpox
Pharmacokinetics in Pediatric Patients: Drug Distribution
Poliomyelitis
Vaccine Production
Vaccines
Vaccinations

